Response to "COVID-19 in persons with haematological cancers"
Leukemia
.
2020 Aug;34(8):2265-2270.
doi: 10.1038/s41375-020-0914-x.
Epub 2020 Jun 11.
Authors
Stefan Hatzl
#
1
,
Florian Eisner
#
2
,
Gernot Schilcher
2
,
Philipp Kreuzer
3
,
Maximilian Gornicec
1
,
Philipp Eller
2
,
Marianne Brodmann
4
,
Peter Schlenke
5
,
Martin Helmut Stradner
6
,
Robert Krause
7
,
Hildegard Greinix
1
,
Eduard Schulz
8
Affiliations
1
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
2
Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
3
Emergency Medicine Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
4
Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
5
Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria.
6
Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
7
Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
8
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
[email protected]
.
#
Contributed equally.
PMID:
32528043
PMCID:
PMC7289538
DOI:
10.1038/s41375-020-0914-x
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections*
Hematologic Neoplasms*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2